VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 60 filers reported holding VOR BIOPHARMA INC in Q3 2023. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $193,712 | +8749.3% | 62,690 | -84.6% | 0.00% | -100.0% |
| Q1 2023 | $2,189 | -33.9% | 406,851 | -18.3% | 0.00% | -50.0% |
| Q4 2022 | $3,312 | -99.8% | 498,080 | +47.0% | 0.00% | +100.0% |
| Q3 2022 | $1,349,000 | -6.1% | 338,921 | +17.3% | 0.00% | 0.0% |
| Q2 2022 | $1,436,000 | +1336.0% | 288,942 | +1639.3% | 0.00% | – |
| Q1 2022 | $100,000 | -70.8% | 16,613 | -9.4% | 0.00% | – |
| Q2 2021 | $342,000 | – | 18,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 6,361,723 | $13,486,853 | 3.88% |
| OUP Management Co., LLC | 374,714 | $794,394 | 1.79% |
| RA Capital Management | 22,748,880 | $48,227,626 | 0.95% |
| Paradigm Biocapital Advisors LP | 6,461,467 | $13,698,310 | 0.93% |
| JOHNSON & JOHNSON | 1,074,658 | $2,278,275 | 0.84% |
| Trustees of Columbia University in the City of New York | 91,910 | $194,849 | 0.36% |
| Artal Group S.A. | 2,688,015 | $5,699 | 0.24% |
| Sarissa Capital Management LP | 618,000 | $1,310,160 | 0.18% |
| Laurion Capital Management LP | 3,182,889 | $6,747,724 | 0.04% |
| Woodline Partners LP | 1,111,123 | $2,355,581 | 0.03% |